Data as of Dec 06
| +0.61 / +1.65%|
The 16 analysts offering 12-month price forecasts for Abbott Laboratories have a median target of 39.50, with a high estimate of 48.00 and a low estimate of 34.00. The median estimate represents a +5.25% increase from the last price of 37.53.
The current consensus among 24 polled investment analysts is to Hold stock in Abbott Laboratories. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.